Cargando…
A Rare Case of Pembrolizumab-Induced Dermatomyositis in a Patient with Cancer of Unknown Primary Origin
Patient: Female, 71-year-old Final Diagnosis: Dermatomyositis Symptoms: Fever • walking difficulties Medication: — Clinical Procedure: Corticosteroids Specialty: Immunology • Oncology • Rheumatology OBJECTIVE: Rare disease BACKGROUND: Pembrolizumab is a humanized monoclonal antibody against programm...
Autores principales: | Takatsuki, Kensaku, Yanagihara, Toyoshi, Egashira, Ayaka, Ogo, Naruhiko, Yoshizawa, Seiji, Sunami, Syunya, Asoh, Tatsuma, Maeyama, Takashige |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Scientific Literature, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8088784/ https://www.ncbi.nlm.nih.gov/pubmed/33903584 http://dx.doi.org/10.12659/AJCR.930286 |
Ejemplares similares
-
A Case of Drug-Induced Interstitial Lung Disease Caused by Epirubicin and Cyclophosphamide Therapy Before Breast Cancer Surgery
por: Egashira, Ayaka, et al.
Publicado: (2021) -
Nintedanib and intensive immunosuppressive therapy to treat rapidly progressive interstitial lung disease presenting anti-ARS antibodies
por: Yanagihara, Toyoshi, et al.
Publicado: (2020) -
A fatal case of diffuse alveolar hemorrhage complicated by rheumatoid arthritis
por: Nakashima, Kazuki, et al.
Publicado: (2021) -
Tacrolimus Treatment for Post-COVID-19 Interstitial Lung Disease
por: Ohgushi, Migiwa, et al.
Publicado: (2021) -
Three cases of sequential treatment with nintedanib following pulsed-dose corticosteroids for acute exacerbation of interstitial lung diseases
por: Nakashima, Kazuki, et al.
Publicado: (2021)